| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
865,920,000 |
| Market
Cap: |
15.27(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$18.02 - $35.94 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 9.8 |
| Insider 6 Months : 11.7 |
| Insider 3/6 Months : 21.5 |
|
| Guru Rank Number : 221 |
| Guru Rank Value : 5.5 |
| Guru Occurances : 2 |
|
|
|
|
|
| |
|
Company Profile Walgreens Boots Alliance is a holding company. Through its subsidiaries, Co. is engaged in retail pharmacy. Co.'s reportable segments are: U.S., which consists its Walgreens business including the operations of retail drugstores, health and wellness services, and mail and other pharmacy services with principal retail pharmacy brands such as Walgreens and Duane Reade, and its equity method investment in AmerisourceBergen Corporation; and International, which consists of pharmacy-led health and beauty retail businesses outside the U.S. with principal retail pharmacy brands such as Boots, Benavides and Ahumada, and the pharmaceutical wholesaling and distribution business in Germany.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
13,456 |
23,456 |
28,628 |
28,628 |
| Total Buy Value |
$270,423 |
$512,643 |
$659,627 |
$659,627 |
| Total People Bought |
3 |
4 |
5 |
5 |
| Total Buy Transactions |
3 |
4 |
5 |
5 |
| Total Shares Sold |
0 |
16,209 |
16,209 |
43,082 |
| Total Sell Value |
$0 |
$371,017 |
$371,017 |
$1,446,053 |
| Total People Sold |
0 |
2 |
2 |
3 |
| Total Sell Transactions |
0 |
2 |
2 |
4 |
| End Date |
2024-01-18 |
2023-10-17 |
2023-04-18 |
2022-04-18 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Bhandari Inderpal S |
Director |
– • – |
2024-04-11 |
4 |
B |
$18.05 |
$54,150 |
D/D |
3,000 |
3,000 |
2.39 |
-2% |
|
| Mahajan Manmohan |
EVP and Global CFO |
• – – |
2024-04-02 |
4 |
B |
$19.38 |
$116,280 |
D/D |
6,000 |
166,969 |
2.74 |
-6% |
|
| Brown Tracey D |
EVP, Pres., Walgreens Retail |
• – – |
2024-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
11,219 |
168,275 |
|
- |
|
| Fabbri Beth Amber L. |
Chief Corp. Affairs Officer |
• – – |
2024-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
14,052 |
52,822 |
|
- |
|
| Heckman Todd |
SVP, Global Controller and CAO |
• – – |
2024-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
12,541 |
41,164 |
|
- |
|
| Mahajan Manmohan |
EVP and Global CFO |
• – – |
2024-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
101,874 |
160,969 |
|
- |
|
| Jarrett Valerie B |
Director |
– • – |
2024-01-29 |
4 |
B |
$22.44 |
$99,993 |
D/D |
4,456 |
4,456 |
2.39 |
-22% |
|
| Fabbri Beth Amber L. |
Chief Corp. Affairs OfficerOff |
• – – |
2024-01-25 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
38,341 |
|
-24% |
|
| Schlichting Nancy M |
Director |
– • – |
2024-01-16 |
4 |
S |
$23.05 |
$350,567 |
D/D |
(15,209) |
0 |
|
23% |
|
| Wentworth Timothy C |
Chief Executive Officer |
• • – |
2024-01-05 |
4 |
B |
$24.22 |
$242,220 |
D/D |
10,000 |
585,122 |
2.81 |
-29% |
|
| Gates Richard P. |
SVP, Chief Pharmacy Officer |
• – – |
2023-11-10 |
4 |
S |
$20.45 |
$20,450 |
D/D |
(1,000) |
73,929 |
|
1% |
|
| Barra Ornella |
Chief Operating Officer, Intl |
• – – |
2023-10-25 |
4 |
D |
$21.37 |
$151,492 |
D/D |
(7,089) |
371,066 |
|
- |
|
| Barra Ornella |
Chief Operating Officer, Intl |
• – – |
2023-10-25 |
4 |
A |
$0.00 |
$0 |
D/D |
52,167 |
378,155 |
|
- |
|
| Mahajan Manmohan |
SVP and Interim Global CFO |
• – – |
2023-10-25 |
4 |
D |
$21.37 |
$25,409 |
D/D |
(1,189) |
24,894 |
|
- |
|
| Mahajan Manmohan |
SVP and Interim Global CFO |
• – – |
2023-10-25 |
4 |
A |
$0.00 |
$0 |
D/D |
4,057 |
26,083 |
|
- |
|
| Gates Richard P. |
SVP, Chief Pharmacy Officer |
• – – |
2023-10-25 |
4 |
D |
$21.37 |
$25,409 |
D/D |
(1,189) |
29,447 |
|
- |
|
| Gates Richard P. |
SVP, Chief Pharmacy Officer |
• – – |
2023-10-25 |
4 |
A |
$0.00 |
$0 |
D/D |
4,057 |
30,636 |
|
- |
|
| Ban Kevin M. |
EVP, Chief Medical Officer |
• – – |
2023-10-25 |
4 |
D |
$21.37 |
$41,308 |
D/D |
(1,933) |
33,039 |
|
- |
|
| Ban Kevin M. |
EVP, Chief Medical Officer |
• – – |
2023-10-25 |
4 |
A |
$0.00 |
$0 |
D/D |
5,796 |
34,972 |
|
- |
|
| Heckman Todd |
Interim Global Controller |
• – – |
2023-10-25 |
4 |
D |
$21.37 |
$18,143 |
D/D |
(849) |
12,213 |
|
- |
|
| Heckman Todd |
Interim Global Controller |
• – – |
2023-10-25 |
4 |
A |
$0.00 |
$0 |
D/D |
2,898 |
13,062 |
|
- |
|
| Pessina Stefano |
Executive Chairman of Board |
• • • |
2023-10-25 |
4 |
A |
$0.00 |
$0 |
D/D |
207,039 |
1,057,265 |
|
- |
|
| Heckman Todd |
Interim Global ControllerOffic |
• – – |
2023-07-27 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
10,044 |
|
-32% |
|
| Driscoll John Patrick |
EVP, Pres. U.S. Healthcare |
• – – |
2023-06-30 |
4 |
B |
$28.42 |
$146,984 |
D/D |
5,172 |
59,050 |
2.74 |
-24% |
|
| Gray Danielle |
EVP and Global CLO |
• – – |
2023-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
32,982 |
79,645 |
|
- |
|
287 Records found
|
|
Page 1 of 12 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.01 (0.06%) 
